We are live on ! Find out more
BCDA icon

BioCardia
BCDA

19 hedge funds and large institutions have $13.5M invested in BioCardia in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

127% more capital invested

Capital invested by funds: $5.96M → $13.5M (+$7.57M)

19% more funds holding

Funds holding: 16 → 19 (+3)

0.57% more ownership

Funds ownership: 0.71% → 1.27% (+0.57%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $540K

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
8
Reduced
3
Closed
2
Calls
–
Puts
$540K
Net Calls
-$540K
Net Calls Change
-$540K

Top Buyers

Rank Fund Capital Flow
1
RAM
Roumell Asset Management
Maryland
+$2.88M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.27M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$624K
4
CM
CM Management
Florida
+$346K
5
Squarepoint
Squarepoint
New York
+$196K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$28.4K
2
UBS Group
UBS Group
Switzerland
-$15K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$4.56K
4
Bank of America
Bank of America
North Carolina
-$3.75K
Name Holding Trade Value Shares
Change 		Change in
Stake
RAM
1
Roumell Asset Management
Maryland
$5.46M +$2.88M +46,140 +122%
CAPTRUST Financial Advisors
2
CAPTRUST Financial Advisors
North Carolina
$2.86M – – –
CM
3
CM Management
Florida
$1.36M +$346K +5,540 +36%
Renaissance Technologies
4
Renaissance Technologies
New York
$1.32M +$1.27M +20,347 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.06M +$624K +9,992 +157%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$269K +$165K +2,641 +176%
Squarepoint
7
Squarepoint
New York
$204K +$196K +3,130 New
Osaic Holdings
8
Osaic Holdings
Arizona
$192K +$3.12K +50 +2%
Marshall Wace
9
Marshall Wace
United Kingdom
$173K +$166K +2,664 New
Brown Advisory
10
Brown Advisory
Maryland
$144K – – –
Simplex Trading
11
Simplex Trading
Illinois
$100K +$96.4K +1,543 New
EGM
12
Engineers Gate Manager
New York
$95K +$91K +1,457 New
Citadel Advisors
13
Citadel Advisors
Florida
$94K +$20.6K +330 +30%
Northern Trust
14
Northern Trust
Illinois
$83K +$5.25K +84 +7%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$66K -$4.56K -73 -7%
Bank of America
16
Bank of America
North Carolina
$25K -$3.75K -60 -14%
TRCT
17
Tower Research Capital (TRC)
New York
$14K -$28.4K -455 -68%
Morgan Stanley
18
Morgan Stanley
New York
$4K – – –
UBS Group
19
UBS Group
Switzerland
– -$15K -290 Closed
Wells Fargo
20
Wells Fargo
California
– +$62 +1 +25%

BCDA Hedge Fund Activity: Q1 2021 in Review

19 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q1 2021, worth a combined $13.5M — up 127% from $5.96M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BCDA positions and 2 closed out — a net gain of 3 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Roumell Asset Management, adding an estimated $2.88M. The largest seller was Tower Research Capital (TRC), cutting an estimated $28.4K.

  • 19 institutional investors held BioCardia (BCDA) as of Q1 2021, up from 16 in Q4 2020.
  • Funds reported $13.5M of BioCardia stock for Q1 2021, up 127% quarter-over-quarter.
  • 5 funds opened new BioCardia positions in Q1 2021 and 2 closed out, a net change of +3 holders.
  • The largest BioCardia buyer in Q1 2021 was Roumell Asset Management, an estimated $2.88M added.
  • The largest BioCardia seller in Q1 2021 was Tower Research Capital (TRC), an estimated $28.4K sold.

Based on aggregated 13F filings for Q1 2021.